These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 11256772

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical inquiries. What is the best strategy for monitoring the lipid-lowering effects of medical therapy used for the primary prevention of coronary artery disease (CAD)?
    Sherrod JP, Krist A.
    J Fam Pract; 2001 Nov; 50(11):928. PubMed ID: 11711006
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The VA HDL intervention trial: clinical implications.
    Rubins HB, Collins D, Robins SJ.
    Eur Heart J; 2000 Jul; 21(14):1113-5. PubMed ID: 10924289
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
    Malloy MJ, Kane JP.
    Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050
    [No Abstract] [Full Text] [Related]

  • 7. Managing dyslipidemia in adults with diabetes.
    Haffner SM.
    Manag Care; 2003 Sep; 12(9 Suppl):10-5. PubMed ID: 14535130
    [No Abstract] [Full Text] [Related]

  • 8. [High cholesterol levels are discriminated by new therapeutic recommendations].
    Olsson AG.
    Lakartidningen; 2000 Apr 19; 97(16):1995-6. PubMed ID: 10826361
    [No Abstract] [Full Text] [Related]

  • 9. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
    Sarawate CA, Cziraky MJ, Stanek EJ, Willey VJ, Corbelli JC, Charland SL.
    Clin Ther; 2007 Jan 19; 29(1):196-209. PubMed ID: 17379061
    [Abstract] [Full Text] [Related]

  • 10. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD, Banga JD, Erkelens DW.
    Ned Tijdschr Geneeskd; 2001 Apr 21; 145(16):769-74. PubMed ID: 11346913
    [Abstract] [Full Text] [Related]

  • 11. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP, Pépin GM, Mahley RW.
    Am Heart J; 2003 Dec 21; 146(6):1052-9. PubMed ID: 14660998
    [Abstract] [Full Text] [Related]

  • 12. Cholesterol and coronary artery disease--issues in the 1990s.
    Chia BL.
    Singapore Med J; 1991 Oct 21; 32(5):291-4. PubMed ID: 1788566
    [No Abstract] [Full Text] [Related]

  • 13. The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.
    Manuel DG, Tanuseputro P, Mustard CA, Schultz SE, Anderson GM, Ardal S, Alter DA, Laupacis A.
    CMAJ; 2005 Apr 12; 172(8):1027-31. PubMed ID: 15824409
    [No Abstract] [Full Text] [Related]

  • 14. Underidentification and undertreatment of dyslipidemia.
    Clearfield MB.
    J Am Osteopath Assoc; 2003 Jan 12; 103(1 Suppl 1):S5-8. PubMed ID: 12572623
    [Abstract] [Full Text] [Related]

  • 15. [Drug therapy of dyslipidemias].
    Fonda M, Cattin L, Guarnieri G.
    Recenti Prog Med; 2000 Jan 12; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract] [Full Text] [Related]

  • 16. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM, Levy RI.
    Cardiovasc Clin; 1974 Jan 12; 6(2):1-8. PubMed ID: 4374303
    [No Abstract] [Full Text] [Related]

  • 17. [Effect of micronized fenofibrate (lipantyl-200M) on synthesis of cholesterol in peripheral blood lymphocytes of patients with ischemic heart disease and hyperlipidemia].
    Ivanova TN, Poliakova ED, Olfer'ev AM, Perova NV.
    Biull Eksp Biol Med; 1998 May 12; 125(5):569-73. PubMed ID: 9644562
    [No Abstract] [Full Text] [Related]

  • 18. [Lipid-lowering therapy in patients with type-2 diabetes mellitus].
    Pados G, Audikovszky M.
    Orv Hetil; 2003 Mar 23; 144(12):557-61. PubMed ID: 12723526
    [Abstract] [Full Text] [Related]

  • 19. Coronary heart disease in HIV-infected persons.
    Glesby MJ.
    AIDS Read; 2003 Apr 23; 13(4 Suppl):S15-9. PubMed ID: 12762289
    [Abstract] [Full Text] [Related]

  • 20. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
    Mosca L, Merz NB, Blumenthal RS, Cziraky MJ, Fabunmi RP, Sarawate C, Watson KE, Willey VJ, Stanek EJ.
    Circulation; 2005 Feb 01; 111(4):488-93. PubMed ID: 15687138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.